Literature DB >> 20006609

Sharp-1 modulates the cellular response to DNA damage.

Jian-Jun Liu1, Teng-Kai Chung, Jiali Li, Reshma Taneja.   

Abstract

DNA damage checkpoints are essential for maintenance of genome integrity. We report here that inducible overexpression of the transcription factor Sharp-1 results in an S and G2/M cell cycle arrest, concomitant with the upregulation of Brca1 and GADD45alpha expression. In addition, we show that endogenous Sharp-1 mRNA is increased by DNA-damaging agents. Consistently, Sharp-1 overexpressing cells exhibit reduced apoptosis in response to chemotherapeutic drugs along with lower p53 expression and activity. Our studies identify a novel function for Sharp-1 in cell cycle arrest and DNA damage-induced apoptosis. Inappropriate Sharp-1 expression may therefore be associated with tumorigenesis. 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006609      PMCID: PMC2812643          DOI: 10.1016/j.febslet.2009.12.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

Review 1.  The G2-phase DNA-damage checkpoint.

Authors:  M J O'Connell; N C Walworth; A M Carr
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

Review 2.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

3.  mSharp-1/DEC2, a basic helix-loop-helix protein functions as a transcriptional repressor of E box activity and Stra13 expression.

Authors:  Sameena Azmi; Hong Sun; Anne Ozog; Reshma Taneja
Journal:  J Biol Chem       Date:  2003-03-25       Impact factor: 5.157

Review 4.  Phosphorylation of serine 10 in histone H3, what for?

Authors:  Claude Prigent; Stefan Dimitrov
Journal:  J Cell Sci       Date:  2003-09-15       Impact factor: 5.285

5.  Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells.

Authors:  R V Gopalkrishnan; K A Christiansen; N I Goldstein; R A DePinho; P B Fisher
Journal:  Nucleic Acids Res       Date:  1999-12-15       Impact factor: 16.971

Review 6.  Regulation of the G2/M transition by p53.

Authors:  W R Taylor; G R Stark
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

7.  bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis.

Authors:  M E McCurrach; T M Connor; C M Knudson; S J Korsmeyer; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 8.  DNA damage tumor suppressor genes and genomic instability.

Authors:  Noboru Motoyama; Kazuhito Naka
Journal:  Curr Opin Genet Dev       Date:  2004-02       Impact factor: 5.578

9.  p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.

Authors:  Andreas Villunger; Ewa M Michalak; Leigh Coultas; Franziska Müllauer; Gunther Böck; Michael J Ausserlechner; Jerry M Adams; Andreas Strasser
Journal:  Science       Date:  2003-09-18       Impact factor: 47.728

Review 10.  Tumour suppression by p53: a role for the DNA damage response?

Authors:  David W Meek
Journal:  Nat Rev Cancer       Date:  2009-09-04       Impact factor: 60.716

View more
  6 in total

Review 1.  ATM protein kinase: the linchpin of cellular defenses to stress.

Authors:  Shahzad Bhatti; Sergei Kozlov; Ammad Ahmad Farooqi; Ali Naqi; Martin Lavin; Kum Kum Khanna
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

2.  Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23).

Authors:  E A Coenen; C M Zwaan; J Stary; A Baruchel; V de Haas; R W Stam; D Reinhardt; G J L Kaspers; S T C J M Arentsen-Peters; C Meyer; R Marschalek; L L Nigro; M Dworzak; R Pieters; M M van den Heuvel-Eibrink
Journal:  Leukemia       Date:  2014-02-24       Impact factor: 11.528

3.  Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.

Authors:  Yiping Huang; Dafna Kesselman; Darya Kizub; Rafael Guerrero-Preston; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2013-01-23       Impact factor: 4.534

4.  Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions.

Authors:  Hideaki Nakamura; Hidemasa Bono; Keiko Hiyama; Takeshi Kawamoto; Yukio Kato; Takeshi Nakanishi; Masahiko Nishiyama; Eiso Hiyama; Nobuyuki Hirohashi; Eisaburo Sueoka; Lorenz Poellinger; Keiji Tanimoto
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

5.  SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest.

Authors:  Yaju Wang; Vinay Kumar Rao; Wai Kay Kok; Dijendra Nath Roy; Sumita Sethi; Belinda Mei Tze Ling; Martin Beng Huat Lee; Reshma Taneja
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

6.  The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.

Authors:  Akihiko Numata; Hui Si Kwok; Akira Kawasaki; Jia Li; Qi-Ling Zhou; Jon Kerry; Touati Benoukraf; Deepak Bararia; Feng Li; Erica Ballabio; Marta Tapia; Aniruddha J Deshpande; Robert S Welner; Ruud Delwel; Henry Yang; Thomas A Milne; Reshma Taneja; Daniel G Tenen
Journal:  Nat Commun       Date:  2018-04-24       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.